Cargando…
Stimulation of medulloblastoma stem cells differentiation by a peptidomimetic targeting neuropilin-1
Medulloblastoma (MB) is the most common malignant pediatric brain tumor. Despite the progress of new treatments, the risk of recurrence, morbidity, and death remains important. The neuropilin-1 (NRP-1) receptor has recently been implicated in tumor progression of MB, which seems to play an important...
Autores principales: | Gong, Caifeng, Valduga, Julie, Chateau, Alicia, Richard, Mylène, Pellegrini-Moïse, Nadia, Barberi-Heyob, Muriel, Chastagner, Pascal, Boura, Cédric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880606/ https://www.ncbi.nlm.nih.gov/pubmed/29632646 http://dx.doi.org/10.18632/oncotarget.24521 |
Ejemplares similares
-
NRP1 inhibition modulates radiosensitivity of medulloblastoma by targeting cancer stem cells
por: Douyère, Manon, et al.
Publicado: (2022) -
Neuropilin-1: A Key Protein to Consider in the Progression of Pediatric Brain Tumors
por: Douyère, Manon, et al.
Publicado: (2021) -
New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy
por: Kamarulzaman, Ezatul Ezleen, et al.
Publicado: (2015) -
New Crystal Form of Human Neuropilin-1 b1 Fragment with Six Electrostatic Mutations Complexed with KDKPPR Peptide Ligand
por: Goudiaby, Ibrahima, et al.
Publicado: (2023) -
Monte Carlo simulations guided by imaging to predict the in vitro ranking of radiosensitizing nanoparticles
por: Retif, Paul, et al.
Publicado: (2016)